PAULA SPARKMAN: Open Payments
NPI 1952396426 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,147 in 153 payments from 22 companies in 2025. Trend: 2023 $2,776 · 2024 $3,986 · 2025 $5,147
Food & beverage: $4,918Education: $229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $1,177 |
| CSL Behring | 23 | $730 |
| Regeneron Healthcare Solutions, Inc. | 12 | $543 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $312 |
| GlaxoSmithKline, LLC. | 15 | $306 |
| Grifols USA, LLC | 9 | $295 |
| GENZYME CORPORATION | 10 | $284 |
| Genentech USA, Inc. | 10 | $276 |
| Novartis Pharmaceuticals Corporation | 9 | $227 |
| Pharming Healthcare, Inc. | 6 | $218 |
Products named: DUPIXENT, TEZSPIRE, Xolair, NEFFY, Hizentra, AIRSUPRA, FASENRA, Xembify.
Industry payments across TN — which companies pay providers there.
